BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Ya-Jen Chang, Ming-Shiang Wu, Jaw-Town Lin, Richard G. Pestell, Martin J. Blaser, Ching-Chow Chen. Mechanisms for Helicobacter pylori CagA-induced cyclin D1 expression that affect cell cycleCellular Microbiology 2006; 8(11): 1740 doi: 10.1111/j.1462-5822.2006.00743.x
2
Shuo Wei, Hsiao-Ching Yang, Hsiao-Ching Chuang, Jian Yang, Samuel K. Kulp, Pei-Jung Lu, Ming-Derg Lai, Ching-Shih Chen. A Novel Mechanism by Which Thiazolidinediones Facilitate the Proteasomal Degradation of Cyclin D1 in Cancer CellsJournal of Biological Chemistry 2008; 283(39): 26759 doi: 10.1074/jbc.M802160200
3
DAIMING FAN, XUEYONG ZHANG, XITAO CHEN, ZHENXIAN MOU, JIALU HU, SHAOJUAN ZHOU, JIE DING, KAICHUN WU. Bird's-eye view on gastric cancer research of the past 25 yearsJournal of Gastroenterology and Hepatology 2005; 20(3): 360 doi: 10.1111/j.1440-1746.2005.03797.x
4
Peng Gao, Geng-Yin Zhou, Yuan Liu, Jin-Song Li, Jun-Hui Zhen, Yin-Ping Yuan. Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significanceWorld Journal of Gastroenterology 2004; 10(20): 2936-2939 doi: 10.3748/wjg.v10.i20.2936
5
Gang Liao, Ziwei Wang, Neng Zhang, Pujiang Dong. Dominant Negative Epidermal Growth Factor Receptor Inhibits Growth of Human Gastric Cancer Cells by Inducing Cell Cycle Arrest and ApoptosisCancer Biotherapy and Radiopharmaceuticals 2013; 28(6): 450 doi: 10.1089/cbr.2012.1399
6
Diane H. Song, Basabi Rana, Jessica R. Wolfe, Geoffrey Crimmins, Caroline Choi, Chris Albanese, Timothy C. Wang, Richard G. Pestell, M. Michael Wolfe. Gastrin-induced gastric adenocarcinoma growth is mediated through cyclin D1American Journal of Physiology-Gastrointestinal and Liver Physiology 2003; 285(1): G217 doi: 10.1152/ajpgi.00516.2002
7
J Leyden, D Murray, A Moss, M Arumuguma, E Doyle, G McEntee, C O'Keane, P Doran, P MacMathuna. Net1 and Myeov: computationally identified mediators of gastric cancerBritish Journal of Cancer 2006; 94(8): 1204 doi: 10.1038/sj.bjc.6603054
8
Zhi-Gang Zhao, Wen-Lu Shen. Heat shock protein 70 antisense oligonucleotide inhibits cell growth and induces apoptosis in human gastric cancer cell line SGC-7901World Journal of Gastroenterology 2005; 11(1): 73-78 doi: 10.3748/wjg.v11.i1.73
9
Zhe-Yi Han, Kai-Chun Wu, Feng-Tian He, Quan-Li Han, Yong-Zhan Nie, Ying Han, Xiao-Nan Liu, Jian-Yong Zheng, Mei-Hong Xu, Tao Lin, Dai-Ming Fan. Screening and identification of mimotope of gastric cancer associated antigen MGb1-AgWorld Journal of Gastroenterology 2003; 9(9): 1920-1924 doi: 10.3748/wjg.v9.i9.1920
10
Anne Lützen, Hanne Cathrine Bisgaard, Lene Juel Rasmussen. Cyclin D1 expression and cell cycle response in DNA mismatch repair-deficient cells upon methylation and UV-C damageExperimental Cell Research 2004; 292(1): 123 doi: 10.1016/j.yexcr.2003.08.018
11
Ying Han, Zhe-Yi Han, Xin-Min Zhou, Ru Shi, Yue Zheng, Yong-Quan Shi, Ji-Yan Miao, Bo-Rong Pan, Dai-Ming Fan. Expression and function of classical protein kinase C isoenzymes in gastric cancer cell line and its drug-resistant sublinesWorld Journal of Gastroenterology 2002; 8(3): 441-445 doi: 10.3748/wjg.v8.i3.441
12
Yan-Shen Shan, Hui-Ping Hsu, Ming-Derg Lai, Yu-Hsuan Hung, Chih-Yang Wang, Meng-Chi Yen, Yi-Ling Chen. Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancerOncology Letters 2017; 14(4): 4517 doi: 10.3892/ol.2017.6736
13
K Zhang, B Pang, T Xin, X Hou, J Jia, B Feng, L Meng, S Xu, Q Pang. Increased Signal Transducer and Activator of Transcription 3 (STAT3) and Decreased Cyclin D1 in Recurrent Astrocytic Tumours Compared with Paired Primary Astrocytic TumoursJournal of International Medical Research 2011; 39(6): 2103 doi: 10.1177/147323001103900606
14
H. Doucas, G. Garcea, C.P. Neal, M.M. Manson, D.P. Berry. Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significanceEuropean Journal of Cancer 2005; 41(3): 365 doi: 10.1016/j.ejca.2004.11.005
15
Mayer Fishman, Scott Antonia. Novel therapies for renal cell carcinoma – an updateExpert Opinion on Investigational Drugs 2003; 12(4): 593 doi: 10.1517/13543784.12.4.593